2017
DOI: 10.1080/09537104.2016.1254764
|View full text |Cite
|
Sign up to set email alerts
|

Effects of a single bout of strenuous exercise on platelet activation in female ApoE/LDLR−/−mice

Abstract: Strenuous physical exercise leads to platelet activation that is normally counterbalanced by the production of endothelium-derived anti-platelet mediators, including prostacyclin (PGI) and nitric oxide (NO). However, in the case of endothelial dysfunction, e.g. in atherosclerosis, there exists an increased risk for intravascular thrombosis during exercise that might be due to an impairment in endothelial anti-platelet mechanisms. In the present work, we evaluated platelet activation at rest and following a sin… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
10
0
1

Year Published

2018
2018
2025
2025

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 16 publications
(12 citation statements)
references
References 54 publications
1
10
0
1
Order By: Relevance
“…In our study, we used low-dose ASA (12 mg�kg -1 of body weight per day equivalent to~100 mg per day in humans [1]) for long-term treatment to achieve selective inhibition of COX-1-dependent thromboxane A 2 generation in platelets without inhibition of COX-1 and COX-2 elsewhere. The treatment with 12 mg�kg -1 of ASA decreased platelet-dependent TXB 2 generation in breast cancer-bearing mice in the ex vivo assay of stirred blood (Fig 1A) that allows for highly sensitive assessment of platelet activation, as reported by us previously [21]. However, the inhibitory effect of ASA on TXB 2 production and platelet reactivity was not detected in other assays ( Figs 1B, 1C and 3).…”
Section: Plos Onesupporting
confidence: 69%
See 1 more Smart Citation
“…In our study, we used low-dose ASA (12 mg�kg -1 of body weight per day equivalent to~100 mg per day in humans [1]) for long-term treatment to achieve selective inhibition of COX-1-dependent thromboxane A 2 generation in platelets without inhibition of COX-1 and COX-2 elsewhere. The treatment with 12 mg�kg -1 of ASA decreased platelet-dependent TXB 2 generation in breast cancer-bearing mice in the ex vivo assay of stirred blood (Fig 1A) that allows for highly sensitive assessment of platelet activation, as reported by us previously [21]. However, the inhibitory effect of ASA on TXB 2 production and platelet reactivity was not detected in other assays ( Figs 1B, 1C and 3).…”
Section: Plos Onesupporting
confidence: 69%
“…Sample preparation. Blood samples were diluted with saline (5 times) and stirred in alternating directions in 1ml cuvettes with disposable, siliconised stir bars (Chrono-Log, US) for one hour at 37˚C (1,500 rpm; spinning time in one direction: 3 s; acceleration/deceleration: 20,000 rpm�s -1 ) in a specially designed Xyzyk apparatus (Xyzyk Co, Poland), as described previously [21]. To determine the generation of eicosanoids ex vivo in the stirred blood, samples were taken on aspirin (500 μM) after 60 minutes of ex vivo stirring in Xyzyk apparatus and centrifuged to obtain plasma (3000xg, 12 min, 4˚C).…”
Section: Measurement Of Eicosanoid Production By Lc-ms/msmentioning
confidence: 99%
“…Blood samples were diluted with saline (5 times) and stirred in alternating directions in 1ml cuvettes with disposable, siliconized stir bars (Chrono-Log, US) for one hour in 37°C (1500rpm; spinning time in one direction: 3s; acceleration/deceleration: 20000 rpm·s -1 ) in a specially-designed Xyzyk apparatus (Xyzyk Co, Poland), as described previously [ 48 ]. To determine basal and mechanically-stimulated ex vivo TXB 2 generation in diluted blood, samples were taken on aspirin (500 μM) at the 2 nd and 60 th minute of ex vivo stirring of blood samples and centrifuged to obtain plasma (3000xg, 12 min, 4°C).…”
Section: Methodsmentioning
confidence: 99%
“…Platelet reactivity was assessed according to a previously published protocol with modification . Briefly, subsequent to anesthesia, blood was collected on heparin from the right heart ventricle.…”
Section: Methodsmentioning
confidence: 99%
“…Platelet reactivity was assessed according to a previously published protocol with modification. 37 Briefly, subsequent to anesthesia, blood was collected on heparin from the right heart ventricle. Whole blood was diluted and either directly processed according to a "wash blood" protocol 38 or incubated at 37°C for 60 minutes, with constant stirring in a Xyzyk apparatus (Xyzyk Company, Krakow, Poland) and then processed according to the "wash blood" protocol.…”
Section: Systemic Platelet Reactivitymentioning
confidence: 99%